1st Quarter - Report

KING & SPALDING LLP for JAZZ PHARMACEUTICALS

Firm
Client
Income
$10,000
Expenses
—

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Law Enforcement/Crime/Criminal Justice LAW

Issues related to the DEA quota for production of Xyrem

LobbyistCovered position, as disclosed
THOMAS J SPULAK GC, House Rules Committee; GC, House of Reps.

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.